title: Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
authors.forename: U
authors.initials: U
authors.lastname: Veronesi
authors.forename: G
authors.initials: G
authors.lastname: De Palo
authors.forename: E
authors.initials: E
authors.lastname: Marubini
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: L
authors.initials: L
authors.lastname: Mariani
authors.forename: F
authors.initials: F
authors.lastname: Formelli
authors.forename: A
authors.initials: A
authors.lastname: Decensi
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D017313:Fenretinide / Q000627:therapeutic use*; D006801:Humans; D020452:Journalism / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
chemical_list: D016588:Anticarcinogenic Agents; D017313:Fenretinide